All Products
Also known as
Valsalva Leak Point Pressure, VLPP, Abdominal Leak Point Pressure (ALPP), Leak Point Pressure (LPP), Valsalva LPP, Bladder Leak Point Pressure
Definition
VLPP, or Valsalva Leak Point Pressure, is a urodynamic measurement that quantifies the minimum intravesical pressure during a Valsalva maneuver that causes involuntary urine leakage in the absence of a detrusor contraction.¹ It represents the global competence of the conjunctive forces around the urethra to support increased pressure from the abdominal cavity with transmission to the bladder.² This dynamic test evaluates the integrity of the urethral sphincter and urinary continence mechanism by assessing the bladder neck or proximal urethra response to abdominal pressure.³
During urodynamic testing, VLPP is measured by having the patient perform a Valsalva maneuver (forcible exhalation against a closed mouth, glottis, and nose) while seated with the bladder filled to a specific volume, typically 200mL.⁴ The lowest abdominal pressure that causes urine leakage is recorded as the VLPP, measured in centimeters of water (cmH₂O).
VLPP values are clinically significant in categorizing the severity and type of stress urinary incontinence (SUI). Values below 60 cmH₂O are generally associated with intrinsic sphincter deficiency (ISD), values between 60-90 cmH₂O are considered equivocal, and values above 90 cmH₂O suggest that incontinence is primarily due to urethral hypermobility rather than sphincter incompetence.⁵ This classification, first described by McGuire et al., has important implications for treatment selection and surgical planning in patients with stress urinary incontinence.⁶
Multiple factors can influence VLPP measurements, including bladder volume, catheter size, patient position, and measurement technique, which has led to ongoing discussions about standardization of the procedure.⁷ Despite these limitations, VLPP remains a valuable component of comprehensive urodynamic evaluation in patients with urinary incontinence, particularly when surgical intervention is being considered.
Clinical Context
VLPP is primarily used in the clinical evaluation of patients with stress urinary incontinence (SUI), particularly when surgical intervention is being considered.1 This urodynamic parameter helps clinicians distinguish between different types of SUI and guides treatment selection based on the underlying pathophysiology.
In clinical practice, VLPP measurement is performed as part of a comprehensive urodynamic study. The test is typically conducted with the patient in a seated position with the bladder filled to a specific volume (commonly 200mL).2 The patient is instructed to perform a Valsalva maneuver of gradually increasing intensity until urine leakage is observed or a maximum effort is reached.3 This procedure may be repeated multiple times to ensure accuracy, with the lowest pressure causing leakage being recorded as the VLPP.
VLPP values are interpreted within the following clinical framework:
- VLPP ≤60 cmH₂O: Strongly suggestive of intrinsic sphincter deficiency (ISD), indicating poor urethral coaptation and sphincter function⁴
- VLPP 60-90 cmH₂O: Equivocal zone, may represent a combination of ISD and urethral hypermobility⁵
- VLPP >90 cmH₂O: Suggests urethral hypermobility as the primary cause of incontinence rather than sphincter incompetence⁶
Historically, VLPP has been used to predict surgical outcomes and guide procedure selection. Patients with low VLPP values (<60 cmH₂O) were thought to have higher failure rates with certain surgical procedures, particularly those that primarily address urethral hypermobility without enhancing sphincter function.7 However, recent studies have challenged this paradigm, with some research suggesting that preoperative VLPP may not reliably predict outcomes after modern midurethral sling procedures.6
Despite these controversies, VLPP remains a valuable component of the urodynamic evaluation, especially when combined with other parameters such as maximum urethral closure pressure (MUCP) and clinical assessment of urethral mobility. The integration of these findings helps clinicians develop a comprehensive understanding of the patient’s continence mechanism and select the most appropriate treatment approach.
VLPP measurement is particularly relevant in complex cases of recurrent incontinence, mixed urinary incontinence, or when previous surgical interventions have failed.1 In these scenarios, detailed urodynamic assessment including VLPP can provide critical insights into the underlying pathophysiology and guide subsequent management decisions.